The Amplify Alternative Harvest ETF seeks investment results that generally correspond, before fees and expenses, to the total return of the Prime Alternative Harvest Index. The fund provides exposure to global companies engaged in the cultivation, production, marketing, and distribution of cannabis, including industrial hemp, for medical and non-medical use. The net expense ratio is 0.75%.
MJ is a passively managed, index-tracking fund with a concentrated portfolio of fewer than a dozen direct positions. Its defining structural feature is its roughly 50% allocation to the Amplify Seymour Cannabis ETF (CNBS), a sibling fund that itself invests primarily in U.S. multi-state operators (MSOs) and Canadian licensed producers. Direct holdings are dominated by Canadian cultivators: Tilray Brands (TLRY) at roughly 10%, Cronos Group (CRON) near 10%, Canopy Growth (CGC) at about 7%, followed by SNDL (SNDL), Village Farms (VFF), Aurora Cannabis (ACB), High Tide (HITI), and Organigram (OGI).
Because the fund is effectively a pure-play cannabis basket with heavy overlap across a small number of correlated names, its day-to-day performance tends to track broad cannabis sentiment rather than any single company's fundamentals. This concentration helps explain the magnitude of its recent move. I also checked this using Tickeron’s AI Screener to see how the fund compares to others in the industry.
Over the last 30 days, MJ fell from roughly $27.66 to about $21.85, a decline of approximately 21%. The move was not gradual: the fund peaked near $27.80 in late September, held in the mid-$26 to mid-$27 range through the end of the month, and then broke sharply lower in early October, sliding through the low-$20s in a series of lower closes.
The trailing quarter tells a different, more balanced story. From about $23.07 three months earlier, MJ is down roughly 5%. That modest net decline masks a pronounced round-trip — a rally from the low-$23 range in late July to a peak near $27.80 in late September, followed by a reversal that erased most of those gains. The pattern is best described as trend-driven but highly volatile, with sharp directional swings typical of a narrow, sentiment-sensitive sector.
The decline was led by the same names that powered the prior rally. Canadian licensed producers — Tilray (TLRY), Cronos (CRON), and Canopy Growth (CGC) — together account for a large share of direct exposure, and their shares retreated alongside the broader cannabis complex.
Several factors converged. Cannabis equities are exceptionally responsive to regulatory developments, and the sector had been lifted by optimism around potential U.S. rescheduling of cannabis and related federal reform. As that momentum faded and profit-taking set in, valuations that had run ahead of fundamentals compressed quickly. Canadian producers also remain sensitive to domestic dynamics, including excise-tax burdens and margin pressures, which weigh on sentiment when headline catalysts cool.
The fund's structure magnified the move. With roughly half of assets invested in the Amplify Seymour Cannabis ETF (CNBS) and the remainder concentrated in a handful of correlated Canadian names, there was limited diversification to cushion the decline. The result was a fast, high-beta pullback rather than a measured correction.
Over the past three months, MJ's trajectory was shaped by sector-wide rotation rather than a single catalyst. The late-summer advance reflected renewed risk appetite for cannabis names tied to U.S. regulatory hopes, while the subsequent unwind mirrored the sector's history of sharp reversals once near-term catalysts are delayed or repriced.
Longer-term pressures also persisted. Canadian operators continue to contend with structural headwinds, including excise taxes, price competition, and profitability challenges, while U.S. MSOs — accessed indirectly through CNBS — remain constrained by the lack of full federal legalization and limited banking access. These cyclical and regulatory factors kept the fund range-bound on a net basis even as intra-quarter volatility was substantial. Institutional flows into cannabis ETFs have historically been episodic and sentiment-driven, reinforcing the pattern of concentrated rallies followed by give-backs.
The factors most likely to influence MJ over the coming months are largely regulatory and macro-driven. In the United States, progress on cannabis rescheduling and any movement on federal banking reform remain pivotal catalysts for the MSO-heavy portion of the portfolio. In Canada, excise-tax policy, pricing trends, and the profitability trajectories of major licensed producers will continue to shape the fund's largest direct holdings.
Investors should also monitor the broader macroeconomic environment. Interest-rate expectations and risk appetite influence speculative, growth-oriented sectors disproportionately, and cannabis sits firmly in that category. Currency dynamics between the U.S. dollar and Canadian dollar add another layer of sensitivity for a fund heavily weighted to Canadian issuers. Finally, capital flows into and out of cannabis ETFs themselves can reinforce momentum in either direction, given the sector's relatively small and concentrated investor base. The fund's fund-of-funds structure means the performance of CNBS will remain a central determinant of MJ's returns. From what I see, this regulatory and sentiment overlay makes the next few months particularly important to watch.
When analyzing volatile areas like cannabis, I turn to Tickeron's AI Screener to quickly scan for technical setups, sentiment shifts, and comparable holdings across the industry. The platform lets me apply customizable filters for volatility, patterns, and performance metrics, which helps surface opportunities without manually combing through dozens of names. It has become a regular part of my workflow for staying on top of fast-moving sectors like this one.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
MJ saw its Momentum Indicator move below the 0 level on September 30, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 83 similar instances where the indicator turned negative. In 76 of the 83 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
The Moving Average Convergence Divergence Histogram (MACD) for MJ turned negative on September 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In 36 of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
MJ moved below its 50-day moving average on September 30, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for MJ crossed bearishly below the 50-day moving average on October 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MJ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for MJ entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator entered the oversold zone -- be on the watch for MJ's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 16 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +3.19% 3-day Advance, the price is estimated to grow further. Considering data from situations where MJ advanced for three days, in 189 of 212 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.
MJ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category MiscellaneousSector